Vanguard Renewables announces innovative partnership with AstraZeneca to decarbonize United States medicines manufacturing
June 13, 2023
In a first-of-its-kind collaboration, AstraZeneca (AZN) is partnering with Vanguard Renewables to enable the delivery of renewable natural gas (RNG) to all of its sites in the United States by the end of 2026.
From June 2023, AstraZeneca will begin purchasing RNG produced by Vanguard Renewables for its Newark Campus in Delaware, where the Company packages 26 medicines for distribution across the U.S. and makes medicine formulations for global supply. By 2026, this collaboration will enable as much as 650,000 million British thermal units (MMBtu), or 190,500 megawatt hours (MWh), per year of RNG to be used across AstraZeneca’s U.S. sites, equivalent to the energy required to heat more than 17,800 U.S. homes for a year.
AstraZeneca is taking a science-led, patient-centric approach to deliver improved health outcomes with a lower environmental footprint. As heat and power are critical to the manufacture of medicines, the decarbonization of healthcare requires access to clean sources of heat, such as renewable natural gas. This new partnership with Vanguard Renewables is an important milestone in delivering emissions reductions in line with AstraZeneca’s flagship Ambition Zero Carbon program. The Company is on track to reduce greenhouse gas (GHG) emissions from its global operations (Scope 1 and 2) by 98% by 2026 from a 2015 baseline, and by 2030, AstraZeneca aims to halve its entire value chain footprint on the way to becoming science-based net zero by 2045 at the latest. The use of RNG at AstraZeneca sites in the U.S. will further enable the company’s transition to 100 percent renewable energy for heat and power. This agreement will utilize Vanguard Renewables Farm Powered® process, allowing Vanguard Renewables to work with dairy farmers and food and beverage manufacturers, retailers and distributors to produce RNG using farm-based anaerobic digestion (AD) from food and dairy cow manure. Once the RNG is produced and captured through AD, it will be injected into existing natural gas infrastructure for use in AstraZeneca medicines research and manufacturing processes. Through the partnership with Vanguard Renewables, AstraZeneca will access high quality RNG from three on-farm anaerobic digester facilities across the U.S. for the next 15 years or more.
This collaboration will utilize food and waste from local and family-owned farms, supporting rural communities across the U.S. By capturing methane from dairy operations that would have otherwise ended up in the atmosphere, this partnership also reduces pollution from the farming sector. John Hanselman, Chief Strategy Officer at Vanguard Renewables shared: “We have been working with multi-generational farms and food and beverage manufacturers since 2014 to provide sustainable solutions to greenhouse gas emissions challenges by diverting food waste from landfills and sequestering on-farm emissions. Vanguard’s Farm Powered process provides farmers across the U.S. with additional revenue streams, supports regenerative agriculture practices, and helps to ensure that these farms will be operating for years to come – thanks in part to change-making partnerships like this with AstraZeneca.”